Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation of infliximab in Crohn's disease patients in sustained complete remission
2012-002702-51Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Aug 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of infliximab in Crohn's disease (2 arms), sponsored by University Hospital Odense. Started Aug 2012; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2012-002702-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002702-51.